Credit Suisse’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-75,752
| Closed | -$1.35M | – | 3446 |
|
|
2018
Q3 | $1.35M | Buy |
75,752
+22,848
| +43% | +$406K | ﹤0.01% | 2214 |
|
|
2018
Q2 | $729K | Buy |
+52,904
| New | +$729K | ﹤0.01% | 2790 |
|
|
2017
Q1 | – | Sell |
-15,265
| Closed | -$39K | – | 3729 |
|
|
2016
Q4 | $39K | Sell |
15,265
-5,915
| -28% | -$15.1K | ﹤0.01% | 3675 |
|
|
2016
Q3 | $66K | Sell |
21,180
-5,128
| -19% | -$16K | ﹤0.01% | 3645 |
|
|
2016
Q2 | $84K | Buy |
26,308
+1,826
| +7% | +$5.83K | ﹤0.01% | 3779 |
|
|
2016
Q1 | $77K | Sell |
24,482
-14,910
| -38% | -$46.9K | ﹤0.01% | 3558 |
|
|
2015
Q4 | $158K | Buy |
39,392
+26,252
| +200% | +$105K | ﹤0.01% | 3750 |
|
|
2015
Q3 | $60K | Sell |
13,140
-57,344
| -81% | -$262K | ﹤0.01% | 3938 |
|
|
2015
Q2 | $366K | Sell |
70,484
-723
| -1% | -$3.75K | ﹤0.01% | 3632 |
|
|
2015
Q1 | $446K | Sell |
71,207
-15,014
| -17% | -$94K | ﹤0.01% | 3362 |
|
|
2014
Q4 | $542K | Buy |
86,221
+28,156
| +48% | +$177K | ﹤0.01% | 3298 |
|
|
2014
Q3 | $353K | Buy |
58,065
+19,494
| +51% | +$119K | ﹤0.01% | 3464 |
|
|
2014
Q2 | $254K | Sell |
38,571
-154,061
| -80% | -$1.01M | ﹤0.01% | 3789 |
|
|
2014
Q1 | $4.59M | Buy |
192,632
+95,858
| +99% | +$2.28M | ﹤0.01% | 1602 |
|
|
2013
Q4 | $1.03M | Buy |
96,774
+21,289
| +28% | +$227K | ﹤0.01% | 2859 |
|
|
2013
Q3 | $1.01M | Buy |
75,485
+13,717
| +22% | +$183K | ﹤0.01% | 2572 |
|
|
2013
Q2 | $811K | Buy |
+61,768
| New | +$811K | ﹤0.01% | 2595 |
|